| Detected | Trial | Change |
|---|---|---|
| 2026-05-15 | NCT07556549 A Study to Learn About Study Medicine Lorlatinib, as a First-line Treatment in Chinese… |
overall status: "Not Yet Recruiting" → "Active Not Recruiting" |
| First Posted | Trial | Phase | Status |
|---|---|---|---|
| 2026-06-01 | NCT07617337 AQUA07 in Patients With ALK-Positive Non-Small Cell Lung Cancer | Phase 1 | Not Yet Recruiting |
| NCT ID | Title | Condition | Status |
|---|---|---|---|
| Phase 4 | |||
| NCT06282874 | Lorlatinib in Patients With ALK-Positive NSCLC With Brain or Leptomeningeal Metastases | Carcinoma, Non-Small-Cell Lung | Active, Not Recruiting |
| Phase 3 | |||
| NCT03126916 | Testing the Addition of 131I-MIBG or Lorlatinib to Intensive Therapy in People With… | Ganglioneuroblastoma | Recruiting |
| Phase 2 | |||
| NCT07415005 | Lorlatinib Plus Local Consolidation Therapy In ALK Positive Advanced Non-Small Cell Lung… | Advanced Non-Small Cell Lung Cancer | Recruiting |
| NCT05740943 | Induction Lorlatinib in Stage III Non-small Cell Lung Cancer | Stage III NSCLC | Active, Not Recruiting |
| NCT05297890 | A Study of Lorlatinib in Subjects With ROS1-Positive Non-Small Cell Lung Cancer | Advanced or Metastatic ROS1-Positive Non-Small Cell Lung Cancer | Active, Not Recruiting |
| Phase 1/2 | |||
| NCT06007937 | A Study of Lorlatinib in Combination With Ramucirumab in People With Lung Cancer | Non Small Cell Lung Cancer | Recruiting |
| Phase 1 | |||
| NCT07617337 | AQUA07 in Patients With ALK-Positive Non-Small Cell Lung Cancer | ALK Positive Non-small Cell Lung Cancer | Not Yet Recruiting |
| Early Phase 1 | |||
| NCT06333899 | Lorlatinib for Newly-Diagnosed High-Grade Glioma With ROS or ALK Fusion | High Grade Glioma | Recruiting |
| Not specified | |||
| NCT05599412 | Post Marketing Surveillance(PMS) Study of Lorviqua in Korea | Metastatic ALK+ Non Small Cell Lung Cancer | Recruiting |
| NCT06487078 | Analysis of the Effectiveness and Safety of Lorlatinib in Untreated ALK-Positive NSCLC… | ALK+ Non-Small-Cell Lung Carcinoma | Recruiting |
| NCT06678555 | A Study to Learn About Lorlatinib in Patients With Non-Small Cell Lung Cancer (NSCLC)… | Carcinoma, Non-Small-Cell Lung | Active, Not Recruiting |
| NCT07567352 | A Study to Learn About Patients With Non-Small Cell Lung Cancer (NSCLC) Who Took… | Non-Small-Cell Lung | Active, Not Recruiting |
| NCT07556549 | A Study to Learn About Study Medicine Lorlatinib, as a First-line Treatment in Chinese… | Non-Small Cell Lung Cancer ALK-positive | Active, Not Recruiting |